ITMCTR2000003187
Not Yet Recruiting
Phase 1
A Clinical study for pricking blood therapy or external application of ''Mo-Ren Gao'' combined with functional exercise in the treatment of knee osteoarthritis
Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine0 sitesTBD
Conditionsknee osteoarthritis, KOA
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- knee osteoarthritis, KOA
- Sponsor
- Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
- Status
- Not Yet Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •The diagnostic criteria of KOA refer to the guidelines for the diagnosis and treatment of osteoarthritis (2018 edition) formulated by the Chinese society of traditional Chinese medicine in 2018 \[5].
- •(1\) repeated pain in past one month;
- •(2\) X\-ray film (standing position or weight\-bearing position) showed knee joint space narrowing, subchondral osteosclerosis and/or cystic change, osteophyte formation at joint edge;
- •(3\) aged \>\=50 years;
- •(4\) The morning stiffness time \<\=30min;
- •(5\) With bone friction sound (feeling).
- •Meet (1\) \+ any 2 of (2\), (3\), (4\), (5\) iteams can be diagnosed as knee osteoarthritis.
Exclusion Criteria
- •(1\) for inflammatory arthritis (such as rheumatoid or psoriatic), this study will test subjects for rheumatoid factors, blood sedimentation and anti\-o before inclusion, excluding the possibility of rheumatoid arthritis;
- •(2\) The coagulation dysfunction;
- •(3\) Previous hip/knee replacement surgery or planning to undergo hip/knee surgery during the trial;
- •(4\) Patients with knee joint tumor, tuberculosis, suppuration and disease affecting joint structure and function;
- •(5\) At the same time, the local use of external treatment, such as local treatment;
- •(6\) Patients with diseases that hinder participation in and influence the completion of the study, such as myocardial infarction or stroke, congestive failure, severe chronic obstructive pulmonary disease, cancer, diabetes, severe systemic disease, and severe mental illness in the past three months;
- •(7\) Local skin scar is not suitable for intervention, such as: psoriasis, toxic neuropathy, etc.
- •(8\) Any test drugs being used in the past 30 days;
- •(9\) at the same time to participate in other clinical trials, unable to complete the instruments.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not Yet Recruiting
Phase 1
Pricking blood therapy for chronic urticaria: a randomized controlled trialITMCTR2100005233Hebei University of Chinese Medicine
Recruiting
N/A
Clinical study to evaluate the efficacy of blood purification therapy on cholesterol crystal embolismcholesterol crystal embolismJPRN-UMIN000009306Incorporated administrative agency, Japan Community Health care Organization, Sendai Hospital35
Completed
N/A
Clinical research for hemoperfusion therapy with an immobilized polymyxin B (PMX) fiber column in patients with severe influenza pneumonia in Vietnam and Japasevere influenza pneumoniaJPRN-UMIN000003669Disease Control and Prevention Center10
Not Yet Recruiting
N/A
Clinical Study of Blood Punching and Cupping Therapy for Treatment of Secondary Lymphedema of Lower Limbs Related to Gynecological Malignant TumorsSecondary lower limb lymphedemaITMCTR2100005282The Second Affiliated Hospital of Guangzhou University of Chinese Medicine
Completed
N/A
Clinical study using human blood and PBMCs about IgG4-related disease.JPRN-UMIN000012977ational Institutes of Biomedical Innovation,Health and Nutrition10